13F COMBINATION REPORT
Syncona Portfolio Ltd
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0000950123-23-002324
Total Value
$63.0M
Positions
4
Other Managers
3
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | AUTOLUS THERAPEUTICS PLC | AUTL | 21,346,829 | $40.6M | 64.38% |
| 2 | FREELINE THERAPEUTICS HLDGS | 35655L107 | 21,997,620 | $10.5M | 16.59% |
| 3 | ACHILLES THERAPEUTICS PLC | 00449L102 | 11,086,909 | $10.0M | 15.84% |
| 4 | ADAPTIMMUNE THERAPEUTICS PLC | ADTI | 1,377,294 | $2.0M | 3.19% |